Dr. Rémi Rabasa-Lhoret, a JDRF-funded endocrinologist at the Institut de recherches cliniques de Montréal best known for his work on the...Read More
Type 1 diabetes (T1D) and type 2 diabetes may have little in common, but a new research study has revealed that a drug used to treat the former could also benefit individuals living with T1D.
Diabetes 360⁰ is a framework for a pan-Canadian diabetes strategy aimed at drastically reducing and eventually ending diabetes
Administering multiple insulin injections is one of the many daily burdens for people living with type 1 diabetes (T1D) – particularly among those with a needle phobia. However, a team of scientists is hoping to change all that with the development of an insulin pill to manage the condition.
Up until recently, researchers seeking to unlock the mystery of type 1 diabetes (T1D) relied on many different theories. Some stemmed from autopsy-based studies of human pancreas dating back to the 1960s, while others were from investigations of pancreatic material obtained from rodent models for th...
For most people, a power failure is a huge inconvenience. However, for someone living with type 1 diabetes (T1D), it can be a daunting – and potentially fatal – experience since their insulin needs to be kept refrigerated.
Kaleb Dahlgren joins the #TeamT1D initiative by sharing his thoughts on misconceptions about T1D and the role the Canadian government can play in supporting those living with it.
If you're among those denied the Disability Tax Credit, you may need to reach out to the CRA.
We sat down with our JDRF Marketing & Communications summer student, Evelyn Riddell, who lives with type 1 diabetes (T1D) to get her quick tips on how to drink responsibly with T1D.
JDRF has joined forces with Danish biotech company, Gubra, to develop a glucose-responsive insulin (GRI) as a treatment for people with insulin-dependent diabetes.
Researchers at Oxford University (UK) are offering powdered insulin to babies at high risk of developing type 1 diabetes (T1D) with the hope of training their immune systems to tolerate the insulin they produce, thereby offering life-long protection against the disease.